Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-09-04
1994-03-22
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514338, 546256, 546270, C07D41312, C07D41712, A61K 3144
Patent
active
052964868
ABSTRACT:
Various substituted benzoxazoles, benzothiazoles, oxazolopyridines and thiazolopyridines are described and disclosed, compounds that are potent inhibitors of leukotriene synthesis in warm-blooded animals.
REFERENCES:
patent: 4814459 (1989-03-01), Boesenberg et al.
Advani et al. J. Pharm. Sci. 57 (10) pp. 1693-1696 (1968).
Kaupp et al. Chem. Ber. 119 (5) pp. 1525-1539 (1986).
Adams Julian
Farina Peter
Lazer Edward S.
Miao Clara K.
Boehringer Ingelheim Pharmaceuticals Inc.
Frankhouser D. E.
Ivy C. Warren
Spivack Phyllis G.
Stempel A. R.
LandOfFree
Leukotriene biosynthesis inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Leukotriene biosynthesis inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Leukotriene biosynthesis inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-437282